TREA

98349163 - W

Follow

Information

  • Trademark
  • 98349163
  • Serial Number
    98349163
  • Registration Number
    7658714
  • Filing Date
    January 09, 2024
    a year ago
  • Registration Date
    January 21, 2025
    11 months ago
  • Transaction Date
    January 21, 2025
    11 months ago
  • Status Date
    January 21, 2025
    11 months ago
  • Published for Opposition Date
    December 03, 2024
    a year ago
  • Location Date
    January 20, 2025
    11 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    PULVERMACHER, TASHA
  • Attorney Docket Number
    120075.0118
    Attorney Name
    Sara M. Bauer
  • Owners
Information
Mark Drawing Code
5
Mark Identification
W
Case File Statements
  • DM0000: The mark consists of the stylized letter "W" in gradient shades of dark blue to light blue and dark purple to pink.
  • GS0051: Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders
  • PM0001: WAVE
  • CC0000: The color(s) dark blue, light blue, dark purple, and pink is/are claimed as a feature of the mark.
  • GS0421: Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine, and nucleic acid therapeutics; research, development, and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals
Case File Event Statements
  • 1/9/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/28/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/5/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/7/2024 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/7/2024 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/7/2024 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/6/2024 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/6/2024 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/6/2024 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/7/2024 - a year ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/27/2024 - a year ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/3/2024 - a year ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/3/2024 - a year ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/21/2025 - 11 months ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/21/2025 - 11 months ago
    15 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC